Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
05/28/2013 | US8450097 Protein-proteophore complexes |
05/28/2013 | US8450089 Compounds as L-cystine crystallization inhibitors and uses thereof |
05/28/2013 | US8450067 Method for obtaining anti-idiotype antibodies |
05/28/2013 | US8449979 Molecular aggregate capable of undergoing phase transition by dehydrating condensation and method of phase transition thereof |
05/28/2013 | US8449915 Pharmaceutical composition of nanoparticles |
05/28/2013 | US8449874 Interleukin-1 muteins linked to virus-like particles to treat IL-1 associated diseases |
05/28/2013 | US8449873 Long-term storage of non-glycosylated recombinant Human G-CSF |
05/28/2013 | US8449872 Polymer conjugates of nesiritide peptides |
05/28/2013 | US8449863 Stabilized uncoated particles of reversed liquid crystalline phase materials |
05/28/2013 | US8449773 Method for pretreatment of cellulosic and lignocellulosic materials for conversion into bioenergy |
05/28/2013 | CA2710040C A soluble tumor necrosis factor receptor mutant |
05/28/2013 | CA2592891C Reducing arthritis and lameness in subjects by growth hormone releasing hormone (ghrh) supplementation |
05/28/2013 | CA2586344C G protein coupled receptor agonists and antagonists and methods of use |
05/28/2013 | CA2568305C Insulin-independent, bone morphogenetic protein (bmp)-mediated uptake of blood glucose by peripheral cells and tissues |
05/28/2013 | CA2551183C Process for producing pellets for pharmaceutical compositions |
05/28/2013 | CA2550625C Nutrient compositions and methods for enhanced effectiveness of the immune system |
05/28/2013 | CA2539823C Hemiasterlin derivatives and uses thereof |
05/28/2013 | CA2537137C Use of modified cyclosporins for the treatment of hcv disorders |
05/28/2013 | CA2532475C Formulation for a protein pharmaceutical without added human serum albumin (hsa) |
05/28/2013 | CA2515033C Clk-peptide and slk-peptide |
05/28/2013 | CA2514794C Inhibition of the cd95 ligand/receptor system for the treatment of neurological disorders and injuries |
05/28/2013 | CA2500663C Enteric composition for the manufacture of soft capsule wall |
05/28/2013 | CA2491946C Ghrelin analogs |
05/28/2013 | CA2483145C Transgenic plants with controlled distribution of a trait to progeny |
05/28/2013 | CA2476773C Monoclonal antibodies against extracellular loops of c5ar |
05/28/2013 | CA2464353C Linear basic compounds having nk-2 antagonist activity and formulations thereof |
05/28/2013 | CA2459769C Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses |
05/28/2013 | CA2459367C Methods for construction and screening of libraries of chemokine variants |
05/28/2013 | CA2453301C Synthetic double-stranded oligonucleotides for specific inhibition of gene expression |
05/28/2013 | CA2427902C Compositions and methods for the therapy and diagnosis of ovarian cancer |
05/28/2013 | CA2423876C Novel selective bradykinin (bk) b1 peptidic receptor antagonists and uses thereof |
05/28/2013 | CA2338022C Inhibitors of hiv membrane fusion |
05/28/2013 | CA2323210C Enhancement of intracellular delivery and tissue targeting of drugs and genes |
05/28/2013 | CA2285692C Enhancement of immune response using targeting molecules |
05/28/2013 | CA2240292C Recombinant fusion proteins to growth hormone and serum albumin |
05/23/2013 | WO2013075117A2 Pegylated c-peptide |
05/23/2013 | WO2013075068A1 Polymer protein microparticles |
05/23/2013 | WO2013075027A2 Anti-sil6xr complex binding domains and methods of use |
05/23/2013 | WO2013074966A1 Use of pituitary adenylate cyclase activating polypeptide (pacap) and pacap analogs for treating contrast -indused nephropathy |
05/23/2013 | WO2013074910A1 Glucagon superfamily peptides exhibiting glucocorticoid receptor activity |
05/23/2013 | WO2013074871A2 Humanin analogs |
05/23/2013 | WO2013074820A1 Immunogenic tumor associated stromal cell antigen peptides and methods of their use |
05/23/2013 | WO2013074798A1 Apoaequorin for reducing neuronal injury due to ischemia |
05/23/2013 | WO2013074794A1 Latent human immunodeficiency virus reactivation |
05/23/2013 | WO2013074738A1 Compositions and methods for treating autoimmune and inflammatory disorders |
05/23/2013 | WO2013074636A1 Muscle specific receptor kinase and modulation thereof |
05/23/2013 | WO2013074616A1 Autoclavable suspensions of cyclosporin a form 2 |
05/23/2013 | WO2013074615A1 Compositions and methods for modulating coagulation |
05/23/2013 | WO2013074610A1 Sustained action formulation of cyclosporin form 2 |
05/23/2013 | WO2013074608A1 Cyclosporine a form 2 and method of making same |
05/23/2013 | WO2013074489A1 Conjugates of gm-csf and il-7, compositions and methods related thereto |
05/23/2013 | WO2013074386A2 Hcv ns3 protease inhibitors |
05/23/2013 | WO2013073968A2 Agents for modulation of cell signalling |
05/23/2013 | WO2013073775A1 Novel method for preparing metabolites of atorvastatin using bacterial cytochrome p450 and composition therefor |
05/23/2013 | WO2013073698A1 Cxcr4 activity inhibiting peptide and application thereof |
05/23/2013 | WO2013073648A1 Anti-inflammatory functional agent for oral application |
05/23/2013 | WO2013073545A1 Medicine for treatment and/or improvement of sepsis |
05/23/2013 | WO2013072946A1 Lactoferrin derived peptides for use as broad- spectrum inhibitors of influenza virus infection |
05/23/2013 | WO2013072917A2 Antiviral composition |
05/23/2013 | WO2013072838A1 Cationic antibacterial composition |
05/23/2013 | WO2013072836A1 Use of protein s for treating cancer |
05/23/2013 | WO2013072695A1 Polymyxin derivatives |
05/23/2013 | WO2013072636A1 Peptides that inhibit the interaction between asf1 and histones, and use thereof |
05/23/2013 | WO2013072587A1 Use of fibromodulin and lumican for increasing muscle mass |
05/23/2013 | WO2013072044A1 Co-administration of a parvovirus and a cytokine for therapy of pancreatic cancer |
05/23/2013 | WO2013071715A1 Histone deacetylase inhibitors and synthetic method thereof and use thereof in manufacture of medicaments |
05/23/2013 | WO2013071678A1 Liver cancer polypeptide marker antigen competitive enzyme-linked immunosorbent assay kit |
05/23/2013 | WO2013071440A1 Methods and products for increasing frataxin levels and uses thereof |
05/23/2013 | WO2013071396A1 Oral leptin formulations and uses thereof |
05/23/2013 | WO2013071355A1 Soluble mediator |
05/23/2013 | WO2013048116A3 Erythropoietin-derived peptide and use therefor |
05/23/2013 | WO2013042943A9 Use for glycolipoprotein gintonin, isolated and identified from ginseng, as a natural medicinal-plant-derived ligand |
05/23/2013 | WO2013028615A8 Novel cyclosporin derivatives for the treatment and prevention of viral infections |
05/23/2013 | WO2012125408A8 Pegylated apelin and uses thereof |
05/23/2013 | US20130133092 Sequence-specific dna recombination in eukaryotic cells |
05/23/2013 | US20130133089 High affinity leptins and leptin antagonists |
05/23/2013 | US20130131338 Substituted diketopiperazines as oxytocin antagonists |
05/23/2013 | US20130131317 Expression of secreted human alpha-fetoprotein in transgenic animals |
05/23/2013 | US20130131052 Amelioration Of The Development Of Cataracts And Other Ophthalmic Diseases |
05/23/2013 | US20130130996 Peptides for inhibiting chemokine binding to chemokine receptors |
05/23/2013 | US20130130995 Treatments for Gastrointestinal Disorders |
05/23/2013 | US20130130990 Use of spink6 gene and its encoded protein for the preparation of an anti-tumor drug |
05/23/2013 | US20130130987 Methods for inhibiting immune complex formation in a subject |
05/23/2013 | US20130130986 Cancer treatment with recombinant vector |
05/23/2013 | US20130130985 Oxytocin peptide analogues |
05/23/2013 | US20130130984 Administration Of Heparin Binding Epidermal Growth Factor For The Protection Of Enteric Neurons |
05/23/2013 | US20130130982 Neuroprotection by hepatic cells and hepatocyte secretory factors |
05/23/2013 | US20130130981 Treatment using neublastin polypeptides |
05/23/2013 | US20130130979 Peptides that bind to the erythropoietin receptor |
05/23/2013 | US20130130978 Method of treating endothelial dysfunction |
05/23/2013 | US20130130977 Polymer-based sustained release device |
05/23/2013 | US20130130975 Methods of Treating Glucose Metabolism Disorders |
05/23/2013 | US20130130974 NOVEL SYNTHETIC APPROACH TO beta-AMINOBUTYRYL SUBSTITUTED COMPOUNDS |
05/23/2013 | US20130130972 Artificial sweetners and performance |
05/23/2013 | US20130130971 Method for Inhibiting HIV Replication in Mammal and Human Cells |
05/23/2013 | US20130130968 Compounds for enzyme inhibition |
05/23/2013 | US20130130965 Method to detect and treat infectious or inflammatory diarrhea based on reg1 |
05/23/2013 | US20130130252 Identification of pold2 sequences |
05/23/2013 | US20130130251 Identification of snare ykt6 sequences |
05/23/2013 | US20130130250 Isolated glucokinase genomic polynucleotide fragments from chromosome 7 |